-
- M. Pharm (Pharmacology / Pharmaceutical Analysis) / . (Biochemistry / Pharmaceutical Chemistry) with 7-10 years or Ph.D. with 2-5 years experience
- Expertise in designing and execution of DMPK studies to support ADC as well as antibody programs
- Extensive experience on quantification of antibodies therapeutic protein ADC and peptides using LC-MS/MS or MSD or ELISA.
- Well versed with handling of BioPharma finder Maxquant Spectronaut and other relevant software
- Leverage current and new techniques for function-based identification and selection of antibody-drug-conjugate (ADC) mAb lead drug candidates with the understanding of their DMPK properties ensuring the safe and effective delivery of novel therapeutics.
- Interpret DMPK data and provide insights to project teams.
- Represent the group in internal and external meeting.
- Maintain strong relationship with other departments to understand ADC challenges and propose solutions from target concept to IND stage
- Responsible for preparation of relevant SOP protocolsreports etc. to support various regulatory and non-regulatorysubmission.
|
Strong understanding of various concepts of DMPK including PK-PD tox and excellent communication skills driving innovation managing teams is added advantage